283 related articles for article (PubMed ID: 17630943)
1. Advances in antithrombotic agents.
Chakrabarti R; Das SK
Cardiovasc Hematol Agents Med Chem; 2007 Jul; 5(3):175-85. PubMed ID: 17630943
[TBL] [Abstract][Full Text] [Related]
2. New targets for antithrombotic drugs.
Thiagarajan P
Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
[TBL] [Abstract][Full Text] [Related]
3. Management of thrombotic and cardiovascular disorders in the new millenium.
Fareed J; Hoppensteadt DA; Bick RL
Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377
[TBL] [Abstract][Full Text] [Related]
4. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of low-molecular-weight heparin and antiplatelet therapies in the cardiac catheterization laboratory.
Deutsch E
Am Heart J; 1999 Dec; 138(6 Pt 2):S577-85. PubMed ID: 10577465
[TBL] [Abstract][Full Text] [Related]
6. Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding.
Yu J; Wang T; Zhang X; Chen Q; Hu Y; Liang Q; Shi Y; Wang Y; Zhang Y; Yu M; Zhao B
Thromb Haemost; 2024 Feb; 124(2):108-121. PubMed ID: 37657484
[TBL] [Abstract][Full Text] [Related]
7. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
8. Optimal antithrombotic treatment for percutaneous coronary intervention.
Kadakia RA; Ferguson JJ
Minerva Cardioangiol; 2005 Feb; 53(1):15-42. PubMed ID: 15788977
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
11. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
12. Novel antithrombotic strategies in cardiovascular diseases.
Golino P; Loffredo F; Riegler L; Renzullo E; Cocchia R
Curr Opin Investig Drugs; 2005 Mar; 6(3):298-306. PubMed ID: 15816507
[TBL] [Abstract][Full Text] [Related]
13. Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes.
Harrington RA
Am Heart J; 1999 Oct; 138(4 Pt 2):276-86. PubMed ID: 10502233
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
Fauler J
Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
16. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
Song Q; Wang S; Zhao W
J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
[TBL] [Abstract][Full Text] [Related]
17. [The new antithrombotic agents].
Meyer Samama M
Presse Med; 2005 Oct; 34(18):1309-14. PubMed ID: 16269995
[TBL] [Abstract][Full Text] [Related]
18. [Where to look for progress in antithrombotic treatments?].
Samama MM
Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
[TBL] [Abstract][Full Text] [Related]
19. Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects.
Chackalamannil S
J Med Chem; 2006 Sep; 49(18):5389-403. PubMed ID: 16942011
[No Abstract] [Full Text] [Related]
20. Advances in antithrombotic therapy of acute myocardial infarction.
Gensini GF; Comeglio M; Falai M
Am Heart J; 1999 Aug; 138(2 Pt 2):S171-6. PubMed ID: 10426878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
